STI571 in Treating Patients With Recurrent Leukemia

Completed · Phase 1

Conditions studied: Leukemia

In brief

RATIONALE: Imatinib mesylate may interfere with the growth of cancer cells and may be an effective treatment for leukemia. PURPOSE: Phase I trial to study the effectiveness of imatinib mesylate in treating patients who have recurrent leukemia.

Key facts

Study ID
NCT00004932
Run by
Children's Oncology Group
People needed
31
Starts
2002-01-01
Expected to finish
2005-09-01
Last updated by the study team
2014-02-21

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.